Enable Biosciences Inc.
Diagnostics company · South San Francisco, California, United States
Enable Biosciences Inc. is a diagnostics company headquartered in South San Francisco, California, United States. The US FDA lists 1 medical device site registered to the company, with devices in clinical chemistry. It has received 7 US government small-business research awards (SBIR/STTR) from health agencies, $8.1 million in total, most recently in 2023.
Enable Biosciences at a glance
What does Enable Biosciences do?
Medical specialties of its FDA-listed devices
Device types listed with the FDA
US government research funding
7 SBIR/STTR small-business research awards from US health agencies, $8.1 million in total (2016 to 2023). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases.
Where is Enable Biosciences located?
Headquarters: South San Francisco, California, United States
- South San Francisco, CaliforniaEnable Biosciences · FDA device site
Frequently asked questions about Enable Biosciences
Where is Enable Biosciences headquartered?
Enable Biosciences Inc. is headquartered in South San Francisco, California, United States.
What does Enable Biosciences do?
Enable Biosciences Inc. is a diagnostics company. Its FDA-listed medical devices fall under clinical chemistry.
Similar companies
- Achieve Life Sciences, Inc.Seattle, Washington, United States
- Celldex Therapeutics, Inc.Hampton, New Jersey, United States
- Navidea Biopharmaceuticals, Inc.Dublin, Ohio, United States
- Eyenuk, Inc.Woodland Hills, California, United States
- Visby Medical, Inc.San Jose, California, United States
- Lucira Health, Inc.Emeryville, California, United States
- NeuroTrack Technologies, Inc.Redwood City, California, United States
- Biomerica IncIrvine, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences